DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thalomid (Thalidomide) - White Blood Cell Count Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with White Blood Cell Count Decreased ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Thalomid side effects in male

Reported by a physician from United States on 2012-04-27

Patient: male, weighing 158.9 kg (349.6 pounds)

Reactions: White Blood Cell Count Decreased, Basal Cell Carcinoma, Febrile Neutropenia, Squamous Cell Carcinoma of Skin, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral
    Start date: 2011-11-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-01-01
    End date: 2008-07-18

Melphalan Hydrochloride
    Start date: 2006-01-01
    End date: 2007-01-01

Melphalan Hydrochloride
    Dosage: 2 milligram
    Start date: 2011-04-08

Melphalan Hydrochloride
    End date: 2011-11-21

Thalomid
    Dosage: dose increased
    Start date: 2006-01-01
    End date: 2007-01-01

Thalomid
    Indication: Multiple Myeloma
    Start date: 2004-01-01
    End date: 2005-01-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-08
    End date: 2012-01-12

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-07-01

Revlimid
    Administration route: Oral
    Start date: 2008-07-18

Thalomid
    Start date: 2007-01-01
    End date: 2008-01-01

Other drugs received by patient: Metoclopramide; Clopidogrel; Lovastatin; Zometa; Rocephin; Filgrastim; Lisinopril and Hydrochlorothiazide; Atenolol; Zolpidem; Mupirocin; Neupogen; Warfarin Sodium; Plavix; Hydrocodone Bitartrate + Acetaminophen; Aspirin; Neupogen; Prednisone TAB; Solu-Medrol; Sodium Chloride; Kenalog



Possible Thalomid side effects in male

Reported by a physician from United States on 2012-04-03

Patient: male, weighing 158.9 kg (349.6 pounds)

Reactions: White Blood Cell Count Decreased, Basal Cell Carcinoma, Squamous Cell Carcinoma of Skin, Thrombocytopenia

Drug(s) suspected as cause:
Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2012-01-01

Melphalan Hydrochloride
    Dosage: 2 milligram
    Start date: 2011-04-08

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-07-01

Thalomid
    Indication: Multiple Myeloma
    Start date: 2004-01-01
    End date: 2005-01-01

Thalomid
    Dosage: dose increased
    Start date: 2006-01-01
    End date: 2007-01-01

Thalomid
    Start date: 2007-01-01
    End date: 2008-01-01

Melphalan Hydrochloride
    End date: 2011-11-21

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-01-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-08

Melphalan Hydrochloride
    Start date: 2006-01-01
    End date: 2007-01-01

Other drugs received by patient: Filgrastim; Lovastatin; Metoclopramide; Zometa; Rocephin; Atenolol; Aspirin; Prednisone TAB; Solu-Medrol; Lisinopril and Hydrochlorothiazide; Neupogen; Clopidogrel; Zolpidem; Hydrocodone Bitartrate and Acetaminophen; Warfarin Sodium; Sodium Chloride; Mupirocin; Neupogen; Kenalog



Possible Thalomid side effects in female

Reported by a physician from United States on 2011-12-30

Patient: female

Reactions: White Blood Cell Count Decreased, Intestinal Ischaemia, Septic Shock, Tremor, Paraesthesia

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012